Product Images Tramadol Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Tramadol Hydrochloride NDC 83008-021 by Quality Care Products, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image description - 1
This is a description of a Tramadol HCI ER Tablets USP 300 mg medication. It is manufactured by Lupin Pharmaceuticals, Inc. and packaged and distributed by Zuc&tq @Ma Products, LLC. The medication may be habit-forming and should be kept out of the reach of children. It is a prescription-only medicine, and each extended-release tablet contains 300 mg Tramadol Hydrochloride USP. The lot number is available, and the medication should be used as prescribed. The full prescribing information can be obtained for reference.*
image-1 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 01
image-2 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 02
This is a chart showing the concentration levels of tramadol (measured in ng/mL) over time (measured in hours) for two different types of medication: Tramadol Hydrochloride Extended-Release Tablets (200 mg once per day) and Tramadol Hydrochloride Tablets (50 mg every 6 hours). The concentration levels of tramadol decrease over time for both medications.*
image-3 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 03
This text displays a chart showing the M1 concentration (in ng/mL) over time (in hours) for two different types of tramadol medication: Tramadol Hydrochloride Extended-Release Tablets (at a dosage of 200 mg taken once daily) and Tramadol Hydrochloride Tablets (at a dosage of 50 mg taken every 6 hours).*
image-4 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 04
image-5 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 05
The text appears to be a graph showing the percentage of patients achieving response for Tramadol Hydrochloride Extended-Release Tablets Study 015 for Arthritis Pain Intensity using VAS Responder Analysis. The graph shows different levels of response threshold from baseline with the drug and placebo. The text provides some numerical data but no further information regarding the study or its results.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.